An observational study in Chronic Urticaria, sponsored by Ajou University School of Medicine. Completed at 1 site in Korea, Republic of. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2019-07-08.
Sponsored by Ajou University School of Medicine · Observational
Among 16 studies in Chronic Urticaria with a site in Korea, Republic of — 4 open to participants now, 7 under way, 5 of them phase 3. Chronic Urticaria · Korea, Republic of.
Among the 16 studies in Chronic Urticaria with a site in Korea, Republic of, this one is the only one that started in 2017, is the only observational one, and was the 1st registered.
194 studies on the registry are indexed under Chronic Urticaria; 46 are open to participants now.
Browse Chronic Urticaria studies →4 of the 16 studies in Chronic Urticaria with a site in Korea, Republic of are open now. Recruiting first, the newest first:
Novartis Pharmaceuticals · Sites in Korea, Republic of, Canada, Hong Kong and 1 more country
Ages 18+
Yuhan Corporation · Sites in Korea, Republic of, Bulgaria, China and 1 more country
Ages 18–75
Pfizer · Sites in Korea, Republic of, United States, Bulgaria and 7 more countries
Ages 18+
Celldex Therapeutics · Sites in Korea, Republic of, United States, Argentina and 27 more countries
Ages 18+
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 24 Chronic Urticaria studies recruiting now, 11 (46%) set no upper age limit and 9 (38%) stop at 75 or younger; 1 takes children under 18; 5 take healthy volunteers.
This study: 12 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 1 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 110 is below the median of 165 across 40 observational studies indexed under Chronic Urticaria.
Median enrollment 382 across the 15 interventional studies, 110 across the 1 observational. Of the 9 that completed or were terminated, 7 (78%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 16 have an industry lead sponsor. The 8 most frequent:
Ajou University School of Medicine is the lead sponsor of 173 studies on the registry; 16 are open to participants now.
Ajou University School of Medicine has 1 study filed under Chronic Urticaria — fewer than ten, so there is no comparison to draw.
2 of the studies in Chronic Urticaria with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07219615PfizerA Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults. | 2026-12-25 |
| NCT07415551Yuhan CorporationPhase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines | 2027-06-19 |
Among the 16 studies in Chronic Urticaria with a site in Korea, Republic of, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A randomized open labeled trial to compare the efficacy of antihistamine dosing-up and add-on treatment with H2-receptor antagonist in patients with chronic urticaria
Chronic urticaria in Ajou University Hospital
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Add antihistamines to standard drug therapy
Change to ns-H1RA in standard medication
Standard treatment with ns-H1RA 4X dose
Use of NS 4 kinds for standard treatment
Number of evaluation after 4 weeks treatment by a investigator
0-no effective, 1-ineffective, 2-effective, 3-no symptoms
Time frame: 4 weeks
Peripheral blood eosinophil count
in percentage
Time frame: 4 weeks
Number of evaluation as assessed by questionnaire
Sleepiness, dryness, dysuria
Time frame: 4 weeks
Number of urticaria control by K-UCT
Before and after treatment
Time frame: 4 weeks
Number of urticaria symptom by UAS
Urticaria activity score
Time frame: 4 weeks
Quality of life of chronic urticaria by CU-QoL
Quality of life questionnaire for patients with chronic urticaria
Time frame: 4 weeks
Number of Patient-controlled urticaria by VAS
evaluation of Patient-controlled urticaria
Time frame: 4 weeks
Number of patients using emergency medication
Emergency drug frequency in patients with chronic urticaria
Time frame: 4 weeks
Comparison of Serum total IgE
Comparison each group in treatment activity
Time frame: 4 weeks
Number of physiological parameter
weight gain in kilograms
Time frame: 4 weeks
Number of creatinine, AST/ALT
Creatinine in mg/dl, AST/ALT in UL
Time frame: 4 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Aug 2017 to primary completion in May 2019, 21 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ajou University School of Medicine →